A PROSPECTIVE COMPARATIVE STUDY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) THERAPY WITH THE TOKYO OR CONNAUGHT STRAINS FOR NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Sengiku, Atsushi
Ito, Masaaki
Miyazaki, Yu
Sawazaki, Harutake
Takahashi, Takeshi
Ogura, Keiji
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.2876
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1786
引用
收藏
页码：E734 / E734
页数：1
相关论文
共 50 条
  • [31] BACILLUS CALMETTE-GUERIN (BCG) THERAPY IS SAFE AND EFFECTIVE IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS WITH IMMUNOSUPPRESSIVE CONDITIONS
    Durant, Adri
    Choudry, Mouneeb
    Madura, Grace
    Mi Lanyu
    Tyson, Mark
    Faraj, Kassem
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S59 - S59
  • [32] Intravesical bacille Calmette-Guerin therapy for muscle invasive bladder cancer
    Rosenbaum, RS
    Park, MC
    Fleischmann, J
    UROLOGY, 1996, 47 (02) : 208 - 211
  • [33] Role of immunotherapy in Bacillus Calmette-Guerin unresponsive: non-muscle invasive bladder cancer
    Suh, Jungyo
    Yoo, Sangjun
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6537 - 6545
  • [34] Effect of intravesical Bacillus Calmette-Guerin (BCG) induction therapy on sperm parameters in sexually active male patients diagnosed with non-muscle invasive bladder cancer
    Sahin, S.
    Canitez, I. O.
    Dusunus, Y. E.
    Yentur, S.
    Ulus, I
    Temiz, M. Z.
    Semercioz, A.
    EUROPEAN UROLOGY, 2024, 85 : S1186 - S1186
  • [35] A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer
    Krajewski, Wojciech
    Nowak, Lukasz
    Poletajew, Slawomir
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (06) : 606 - 607
  • [36] A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer
    Sood, Rajeev
    Sharma, Hitt
    Sharma, Bhuvaneshwari
    Parekh, Sameer
    Pujari, Pramod
    Shewale, Sunil
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (05) : 433 - 439
  • [37] FAILURE OF BACILLUS CALMETTE-GUERIN THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER: DEFINITION AND TREATMENT OPTIONS
    Gual Frau, Josep
    Palou, Joan
    Rodriguez, Oscar
    Parada, Ruben
    Breda, Alberto
    Villavicencio, Humberto
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (07): : 423 - 433
  • [38] Intravesical bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: A review
    Saluja, Manmeet
    Gilling, Peter
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (01) : 18 - 24
  • [39] Intravesical docetaxel for high-risk non-muscle invasive bladder cancer after Bacillus Calmette-Guerin failure
    Shantharam, Govind
    Amin, Ali
    Pereira, Jorge
    Kott, Ohad
    Mueller-Leonhard, Catrina
    Mega, Anthony
    Golijanin, Dragan
    Gershman, Boris
    CURRENT UROLOGY, 2021, 15 (01) : 33 - 38
  • [40] Is the role of intravesical bacillus Calmette-Guerin in non-muscle-invasive bladder cancer changing?
    Ayres, Benjamin E.
    Griffiths, T. R. Leyshon
    Persad, Raj A.
    BJU INTERNATIONAL, 2010, 105 : 8 - 13
12345